• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Marchex Announces Second Quarter 2025 Results

    8/12/25 4:15:00 PM ET
    $MCHX
    Real Estate
    Real Estate
    Get the next $MCHX alert in real time by email

    Marchex, Inc. (NASDAQ:MCHX), which harnesses the power of AI and conversational intelligence to drive operational excellence and revenue acceleration, today announced its financial results for the second quarter ended June 30, 2025.

    Q2 2025 Financial Highlights

    • GAAP revenue was $11.7 million for the second quarter of 2025, compared to $12.1 million for the second quarter of 2024.
    • Net income was $0.1 million for the second quarter of 2025 or $0.00 per diluted share, compared to a net loss of $0.8 million or $(0.02) per diluted share for the second quarter of 2024.
    • Adjusted earnings before interest, taxes, depreciation, and amortization ("EBITDA") was a gain of $0.6 million for the second quarter of 2025, compared to a gain of $0.3 million for the second quarter of 2024. Adjusted EBITDA for the second quarter of 2025 includes $0.1 million of reorganization costs and excluding these amounts would result in an Adjusted EBITDA gain of $0.7 million.
    • Adjusted non-GAAP income per share for the second quarter of 2025 was $0.02, compared to a loss per share of ($0.01) for the second quarter of 2024.

    Edwin Miller, Chief Executive Officer ("CEO") of Marchex, commented, "The second quarter represented continued progress toward making 2025 an inflection point for our company. Based on continued technical and product developments, the second quarter saw us accelerate our investment transition into go forward growth initiatives. Additionally, we improved quarterly Adjusted EBITDA, net of reorganization costs, by nearly $1 million over the first quarter of 2025."

    Continued Miller, "Period to period there may be some financial variability based on timing with the new Engage platform migration completion (formerly ‘OneStack'), but our technology and platform progress is leading to increasing operating and cost efficiencies. Collectively, we believe these benefits will accrue to more growth opportunities, gross margin expansion and operating leverage, which also means we can look to increase investment in sales, marketing, and product innovations as we move into 2026."

    THE FOLLOWING FORWARD-LOOKING LOOKING STATEMENTS REFLECT MARCHEX'S EXPECTATIONS AS OF AUGUST 12, 2025

    Marchex currently anticipates that both Revenue and Adjusted EBITDA will sequentially increase in the third quarter of 2025 as compared to the second quarter of 2025, with Adjusted EBITDA potentially increasing by more than 50% over second quarter levels.

    Marchex also currently anticipates that both Revenue and Adjusted EBITDA will be sequentially lower in the fourth quarter of 2025 as compared to the third quarter of 2025, due to the revenue impacts of certain customers not migrating, anticipated seasonality, and current macroeconomic factors, which it is anticipated will delay the achievement of Marchex's annual Revenue and Adjusted EBITDA run rate goals previously set for 2025.

    Added Miller, "Throughout 2025, we have seen operating efficiency benefits begin to highlight the magnitude of our operating leverage, but we have also had to overcome migration revenue dilution, largely based on the timing and success of moving more than 1,000 customers to our new Engage platform throughout 2025, the vast majority of which has been completed. This does have short-term impacts on Revenue, including ancillary factors such as the timing of new sales launches or product utilization. Without these impacts, we would be seeing even higher sequential Revenue and Adjusted EBITDA progress. With that noted, the new Engage platform is a critical company accomplishment, representing a strategically key foundational element of our plan to support a market leading, vertically-focused conversational AI company with a growth path to more than $100 million in annualized revenue over time. With our belief that these primary migration initiatives will be completed by year end, we believe this bodes well for 2026, when sales will be in a position to accelerate on top of the substantial operating cost efficiencies achieved throughout 2025."

    As noted in our first quarter earnings release (the "Q1 Release"), the current macroeconomic environment continues to bring increased uncertainty with customers and prospects. Furthermore, new federal tariffs on imports have begun to have an adverse impact on various industries and vertical markets in which the Company operates, including automotive and auto services. These conditions make predicting actual 2025 performance and timing more difficult. The Company will continue to execute on its 2025 strategic plan, which it believes will lead to more success with new sales to existing and new customers, but acknowledges these conditions raise increased uncertainty regarding customer impacts, and as a result its actual financial results may be more variable in terms of revenue and adjusted EBITDA as reflected above.

    2025 Business Update and Recent Strategic Product and Operational Expansion

    • Strategic Product Launches and Sequential Accelerants: Over the course of 2025, Marchex is significantly expanding its product platform availability for customers and prospects. During the second quarter, Marchex launched its new unified user interface across Marchex's product suite, launched new vertical AI capabilities, and began testing and development of other new products and features, many of which will be launched during the balance of 2025.
    • Gross Profit Margin Expansion: As the company realizes additional SaaS software revenue, increased sales of new products, and continued efficiency from its investments in cloud infrastructure and platform integration, Marchex continues to anticipate meaningful gross margin expansion into the future.
    • New Expanded Partnership with FordDirect: Marchex recently announced an expanded partnership with FordDirect for its Engage for Sales and Service product offering. The new relationship includes multi-year access to its more than 3,000 franchised dealers for Marchex's dealer-facing products. This relationship significantly expands the reach of Marchex's dealer products and gives Ford dealers and retailers unmatched insights into customer interactions, helping drive revenue performance and customer and dealer satisfaction.
    • New AI-Powered Conversational Intelligence Solutions for the Health Care Industry Launched: Marchex continues to expand its industry-leading vertical solutions with recent advancements in AI-driven sentiment analysis and the release of its Health Care solutions, to deliver compliant operational intelligence from patient conversations. Designed for health systems and ambulatory care facilities, the latest release introduces a new healthcare-specific AI solution that identifies patient intent and outcome types, and topics for emerging care needs. Marchex's offerings are tailored to the needs of each key vertical, allowing Marchex to provide prescriptive analytics uniquely calibrated to each industry's omnichannel conversational trends.
    • Channel Expansion and One-to-Many Sales Opportunities: As noted in the Q1 Release, Marchex has launched its initial product into the Microsoft Azure Marketplace and AppSource. By transacting via Azure's global cloud platform, Marchex anticipates it can unlock new sales channels and reach a broader enterprise audience. The Company also expects to launch new products into additional Marketplaces along with other significant integration partners and channel partners throughout 2025 and into 2026.
    • Product Awards: Marchex Engage for Auto Sales and Service recently won the "2025 AI Agent Product of the Year Award" by TMC, a global integrated media company. Marchex Engage for Auto Sales & Service is purpose-built for automotive dealerships and service centers, combining conversation AI and industry-specific intelligence to turn everyday conversations into revenue-generating actions. This award honors groundbreaking AI innovations that elevate performance and deliver outstanding business results across industries and functions.
    • New Company Website: Marchex launched its new corporate website during the second quarter of 2025. The new customer-facing brand reinforces the dynamic characteristics of Marchex new AI-driven product suite for Fortune 500 businesses and more in some of the largest vertical markets.

    Additional New Growth Initiatives Planned for 2025

    • Technology, Product, and Feature Expansion: Marchex anticipates significantly expanding its award-winning suite of AI-powered conversational intelligence solutions throughout 2025 and into 2026, as noted in the Q1 Release. New solutions include:
      • AI Benchmarking: Marchex expects to launch shortly its AI Benchmarking to all customers on the Company's new UI. This will include industry-specific sales and marketing insights driven from real-time customer conversations across the vertical markets for Fortune 500 companies and other customers.
      • AgentAI Optimizer: In the coming months, Marchex expects to launch its AgentAI Optimizer, which prescriptively analyzes the performance and effectiveness of third-party AI-Agents for Fortune 500 businesses and other customers.
      • Marchex GPT: In the second half of 2025, the Company expects to launch Marchex GPT, which is its business-specific, large language model capabilities that enables Fortune 500 and other businesses to effectively search their own structured data.

    Miller concluded, "Marchex is one of the few public AI-powered conversational intelligence companies which is part of a transformative market opportunity and is also generating positive Adjusted EBITDA while increasing investment in customers and products. With the collective benefit of our recent technology, platform and product progress, we have a meaningful opportunity to deliver increased value to our customers, which is what is driving our expanding sales pipeline. As we execute through the balance of 2025 and into 2026, we believe that we are well positioned to successfully deliver on our go forward strategic and financial goals."

    Management will hold a conference call, starting at 5:00 p.m. Eastern Time on Tuesday, August 12, 2025​, to discuss its ​second quarter 2025 financial results and other Company updates. Access to the live webcast of the conference call will be available online from the Investor Relations section of Marchex's website at www.marchex.com. An archived version of the webcast will also be available at the same location two hours after completion of the call.

    About Marchex

    Marchex harnesses the power of AI and conversational intelligence to provide actionable insights aligned with prescriptive vertical market data analytics, driving operational excellence and revenue acceleration. Marchex enables sales, marketing, service, operations, and executive teams to optimize customer journey experiences across omnichannel communication channels. Through our prescriptive analytics solutions, we enable the alignment of enterprise strategy, empowering businesses to increase revenue through informed decision-making and strategic execution. Marchex provides conversational intelligence AI-powered solutions for market-leading companies in leading B2B2C vertical markets, including several of the world's most innovative and successful brands.

    Please visit http://www.marchex.com, www.marchex.com/blog or @marchex on X, where Marchex discloses material information from time to time about the Company, its financial information, and its business.

    Forward-Looking Statements

    This earnings release contains forward-looking statements that involve substantial risks and uncertainties. All statements, other than statements of historical facts, included in this earnings release regarding our strategy, future operations, future financial position, future revenues, other financial guidance, acquisitions, dispositions, projected costs, prospects, plans and objectives of management are forward-looking statements. We may not actually achieve the plans, intentions, or expectations disclosed in our forward-looking statements and you should not place undue reliance on our forward-looking statements. Actual results or events could differ materially from the plans, intentions and expectations disclosed in the forward-looking statements we make. There are a number of important factors that could cause Marchex's actual results to differ materially from those indicated by such forward-looking statements including but not limited to product demand, order cancellations and delays, competition and general economic conditions. These factors are described in greater detail in the "Risk Factors" section of our most recent periodic report and registration statement filed with the Securities and Exchange Commission. All of the information provided in this release is as of ​August 12, 2025,​ and Marchex undertakes no duty to update the information provided herein.

    In the event the earnings release contains links to third party websites or materials, the links are provided solely as a convenience to the user. Marchex is not responsible for the content of linked third-party sites or materials and does not make any representations regarding the content or accuracy thereof.

    Non-GAAP Financial Information

    To supplement Marchex's consolidated financial statements presented in accordance with GAAP and to provide clarity internally and externally, Marchex uses certain non-GAAP measures of financial performance and liquidity, including adjusted EBITDA and adjusted non-GAAP income (loss) per share. Financial analysts and investors may use adjusted EBITDA to help with comparative financial evaluation to make informed investment decisions. Financial analysts and investors may use adjusted non-GAAP income (loss) per share to analyze Marchex's financial performance since these groups have historically used earnings per share related measures, along with other measures, to estimate the value of a Company, to make informed investment decisions, and to evaluate a Company's operating performance compared to that of other companies in its industry.

    Adjusted EBITDA represents net income (loss) before (1) interest, (2) income taxes, (3) amortization of intangible assets from acquisitions, (4) depreciation and amortization, (5) stock-based compensation expense, and (6) acquisition and disposition-related costs. Adjusted EBITDA is a metric by which Marchex has evaluated the performance of its business, to include being the basis on which Marchex's internal budgets have been based and by which Marchex's management has been evaluated. This measure is used by our management to understand and evaluate our core operating performance and trends, and management believes it provides meaningful information regarding the Company's liquidity and ability to fund its operations and financing obligations.

    Adjusted non-GAAP income (loss) per share represents adjusted non-GAAP income (loss) divided by GAAP diluted shares outstanding. Adjusted non-GAAP income (loss) generally captures those items on the statement of operations that have been, or ultimately will be, settled in cash exclusive of certain items that are not indicative of Marchex's recurring core operating results and represents net income (loss) applicable to common stockholders plus the net of tax effects of: (1) stock-based compensation expense, (2) acquisition and disposition related costs, (3) amortization of intangible assets from acquisitions, and (4) interest (income) expense and other, net.

    Marchex's management believes that investors should have access to, and Marchex is obligated to provide, the same set of tools that management uses in analyzing the Company's results. These non-GAAP measures should be considered in addition to results prepared in accordance with GAAP, and should not be considered in isolation, as a substitute for, or superior to, GAAP results. Marchex's non-GAAP financial measures may be defined differently from time to time and may be defined differently than similar titled terms used by other companies, and accordingly, care should be exercised in understanding how Marchex defines its non-GAAP financial measures in this release. Marchex endeavors to compensate for the limitations of the non-GAAP measures presented by providing the comparable GAAP measure with equal or greater prominence, GAAP financial statements, and detailed descriptions of the reconciling items and adjustments, including quantifying such items, to derive the non-GAAP measure.

     

    MARCHEX, INC. AND SUBSIDIARIES

    Consolidated Statements of Operations

    (In Thousands, except per share amounts)

    (Unaudited)

     

     

     

    Three Months Ended

    June 30,

     

    Six Months Ended

    June 30,

     

     

     

    2025

     

     

     

    2024

     

     

     

    2025

     

     

     

    2024

     

    Revenue

     

    $

    11,655

     

     

    $

    12,074

     

     

    $

    23,058

     

     

    $

    23,646

     

    Expenses:

     

     

     

     

     

     

     

     

    Cost of revenue (1)

     

     

    4,058

     

     

     

    4,152

     

     

     

    8,246

     

     

     

    8,566

     

    Amortization of capitalized software development costs

     

     

    10

     

     

     

    —

     

     

     

    10

     

     

     

    —

     

    Total cost of revenue (1)

     

     

    4,068

     

     

     

    4,152

     

     

     

    8,256

     

     

     

    8,566

     

    Sales and marketing (1)

     

     

    3,165

     

     

     

    2,742

     

     

     

    6,431

     

     

     

    5,529

     

    Product development (1)

     

     

    2,501

     

     

     

    3,223

     

     

     

    5,173

     

     

     

    6,468

     

    General and administrative (1)

     

     

    2,457

     

     

     

    2,528

     

     

     

    5,604

     

     

     

    4,817

     

    Amortization of intangible assets from acquisitions

     

     

    —

     

     

     

    151

     

     

     

    —

     

     

     

    301

     

    Total operating expenses

     

    $

    12,191

     

     

    $

    12,796

     

     

    $

    25,464

     

     

    $

    25,681

     

    Loss from operations

     

     

    (536

    )

     

     

    (722

    )

     

     

    (2,406

    )

     

     

    (2,035

    )

    Interest income (expense) and other, net

     

     

    626

     

     

     

    (31

    )

     

     

    623

     

     

     

    (109

    )

    Income (loss) before income tax expense

     

     

    90

     

     

     

    (753

    )

     

     

    (1,783

    )

     

     

    (2,144

    )

    Income tax expense

     

     

    5

     

     

     

    3

     

     

     

    114

     

     

     

    62

     

    Net income (loss) applicable to common stockholders

     

    $

    85

     

     

    $

    (756

    )

     

    $

    (1,897

    )

     

    $

    (2,206

    )

    Basic and diluted net income (loss) per Class A and Class B share applicable to common stockholders

     

    $

    0.00

     

     

    $

    (0.02

    )

     

    $

    (0.04

    )

     

    $

    (0.05

    )

     

     

     

     

     

     

     

     

     

    Shares used to calculate basic net income (loss) per share applicable to common stockholders:

     

     

     

     

     

     

     

     

    Class A

     

     

    4,661

     

     

     

    4,661

     

     

     

    4,661

     

     

     

    4,661

     

    Class B

     

     

    39,241

     

     

     

    38,403

     

     

     

    39,151

     

     

     

    38,398

     

    Shares used to calculate diluted net income (loss) per share applicable to common stockholders:

     

     

     

     

     

     

     

     

    Class A

     

     

    4,661

     

     

     

    4,661

     

     

     

    4,661

     

     

     

    4,661

     

    Class B

     

     

    43,902

     

     

     

    43,064

     

     

     

    43,812

     

     

     

    43,059

     

    (1) Includes stock-based compensation allocated as follows:

     

     

     

     

     

     

     

     

    Cost of revenue

     

    $

    2

     

     

    $

    3

     

     

    $

    3

     

     

    $

    6

     

    Sales and marketing

     

     

    172

     

     

     

    88

     

     

     

    196

     

     

     

    176

     

    Product development

     

     

    78

     

     

     

    14

     

     

     

    105

     

     

     

    22

     

    General and administrative

     

     

    304

     

     

     

    332

     

     

     

    707

     

     

     

    666

     

    Total

     

    $

    556

     

     

    $

    437

     

     

    $

    1,011

     

     

    $

    870

     

     

    MARCHEX, INC. AND SUBSIDIARIES

    Consolidated Balance Sheets

    (In Thousands)

     

     

     

    (Unaudited)

     

     

     

     

    June 30,

     

    December 31,

     

     

     

    2025

     

     

     

    2024

     

    Assets

     

     

     

     

    Current assets:

     

     

     

     

    Cash and cash equivalents

     

    $

    10,491

     

     

    $

    12,767

     

    Accounts receivable, net

     

     

    7,561

     

     

     

    7,072

     

    Prepaid expenses and other current assets

     

     

    3,043

     

     

     

    2,439

     

    Total current assets

     

     

    21,095

     

     

     

    22,278

     

    Property and equipment, net

     

     

    1,736

     

     

     

    1,811

     

    Other assets, net

     

     

    768

     

     

     

    397

     

    Right-of-use lease assets

     

     

    827

     

     

     

    1,156

     

    Goodwill

     

     

    17,558

     

     

     

    17,558

     

    Total assets

     

    $

    41,984

     

     

    $

    43,200

     

    Liabilities and Stockholders' Equity

     

     

     

     

    Current liabilities:

     

     

     

     

    Accounts payable

     

    $

    2,920

     

     

    $

    1,349

     

    Accrued benefits and payroll

     

     

    992

     

     

     

    2,133

     

    Other accrued expenses and current liabilities

     

     

    3,684

     

     

     

    4,197

     

    Deferred revenue and deposits

     

     

    806

     

     

     

    1,093

     

    Operating lease liability, current

     

     

    330

     

     

     

    495

     

    Total current liabilities

     

     

    8,732

     

     

     

    9,267

     

    Deferred tax liabilities

     

     

    658

     

     

     

    579

     

    Operating lease liability, non-current

     

     

    551

     

     

     

    721

     

    Total liabilities

     

     

    9,941

     

     

     

    10,567

     

    Stockholders' equity:

     

     

     

     

    Class A common stock

     

     

    49

     

     

     

    49

     

    Class B common stock

     

     

    393

     

     

     

    390

     

    Additional paid-in capital

     

     

    359,676

     

     

     

    358,372

     

    Accumulated deficit

     

     

    (328,075

    )

     

     

    (326,178

    )

    Total stockholders' equity

     

     

    32,043

     

     

     

    32,633

     

    Total liabilities and stockholders' equity

     

    $

    41,984

     

     

    $

    43,200

     

     

    MARCHEX, INC. AND SUBSIDIARIES

    (In Thousands)

    (Unaudited)

     

    Reconciliation of Net Income (Loss) to Adjusted EBITDA

     

     

     

     

     

     

     

     

     

    Three Months Ended

    June 30,

     

    Six Months Ended

    June 30,

     

     

     

    2025

     

     

     

    2024

     

     

     

    2025

     

     

     

    2024

     

    Net income (loss) applicable to common stockholders

     

    $

    85

     

     

    $

    (756

    )

     

    $

    (1,897

    )

     

    $

    (2,206

    )

    Interest (income) expense and other, net

     

     

    (626

    )

     

     

    31

     

     

     

    (623

    )

     

     

    109

     

    Income tax expense

     

     

    5

     

     

     

    3

     

     

     

    114

     

     

     

    62

     

    Amortization of intangible assets from acquisitions

     

     

    —

     

     

     

    151

     

     

     

    —

     

     

     

    301

     

    Amortization of capitalized software development costs

     

     

    10

     

     

     

    —

     

     

     

    10

     

     

     

    —

     

    Depreciation and amortization

     

     

    618

     

     

     

    385

     

     

     

    1,250

     

     

     

    708

     

    Stock-based compensation

     

     

    556

     

     

     

    437

     

     

     

    1,011

     

     

     

    870

     

    Adjusted EBITDA

     

    $

    648

     

     

    $

    251

     

     

    $

    (135

    )

     

    $

    (156

    )

     

    MARCHEX, INC. AND SUBSIDIARIES

    (In Thousands)

    (Unaudited)

     

    Reconciliation of Net Income (Loss) per Share to Adjusted Non-GAAP Income (Loss)(1)

     

     

     

    Three Months Ended

    June 30,

     

    Six Months Ended

    June 30,

     

     

    2025

     

    2024

     

    2025

     

    2024

    Net income (loss) per share applicable to common stockholders, diluted

     

    $

    0.00

     

    $

    (0.02

    )

     

    $

    (0.04

    )

     

    $

    (0.05

    )

    Stock-based compensation

     

     

    0.01

     

     

    0.01

     

     

     

    0.02

     

     

     

    0.02

     

    Amortization of intangible assets from acquisitions

     

     

    —

     

     

    —

     

     

     

    —

     

     

     

    0.01

     

    Interest income (expense) and other, net

     

     

    0.01

     

     

    —

     

     

     

    0.01

     

     

     

    —

     

    Adjusted non-GAAP income (loss) per share

     

    $

    0.02

     

    $

    (0.01

    )

     

    $

    (0.01

    )

     

    $

    (0.02

    )

    Shares used to calculate diluted net income (loss) per share applicable to common stockholders (GAAP) and adjusted non-GAAP income (loss) per share

     

     

    43,902

     

     

    43,064

     

     

     

    43,812

     

     

     

    43,059

     

    (1)

    For the purpose of computing the number of diluted shares for adjusted non-GAAP income (loss) per share, Marchex uses the accounting guidance that would be applicable for computing the number of diluted shares for GAAP net income (loss) per share.

     

    View source version on businesswire.com: https://www.businesswire.com/news/home/20250812876644/en/

    Trevor Caldwell

    Marchex Investor Relations

    Email: [email protected]

    Or

    MEDIA INQUIRIES

    Marchex Corporate Communications

    Email: [email protected]

    Get the next $MCHX alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $MCHX

    DatePrice TargetRatingAnalyst
    12/28/2021$4.75 → $4.00Buy
    Roth Capital
    More analyst ratings

    $MCHX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Marchex Announces Second Quarter 2025 Results

    Marchex, Inc. (NASDAQ:MCHX), which harnesses the power of AI and conversational intelligence to drive operational excellence and revenue acceleration, today announced its financial results for the second quarter ended June 30, 2025. Q2 2025 Financial Highlights GAAP revenue was $11.7 million for the second quarter of 2025, compared to $12.1 million for the second quarter of 2024. Net income was $0.1 million for the second quarter of 2025 or $0.00 per diluted share, compared to a net loss of $0.8 million or $(0.02) per diluted share for the second quarter of 2024. Adjusted earnings before interest, taxes, depreciation, and amortization ("EBITDA") was a gain of $0.6 million for the

    8/12/25 4:15:00 PM ET
    $MCHX
    Real Estate

    Marchex Releases Healthcare AI Solution to Provide Comprehensive Patient Insights and Superior Marketing Attribution

    New Healthcare AI Solution provides in-depth insights into patient interactions, better connects marketing spend to revenue, and delivers actionable data to improve operations across complex health systems. Marchex (NASDAQ:MCHX), which harnesses the power of AI and conversational intelligence to drive operational excellence and revenue acceleration, today announced the release of its new AI-powered healthcare solution designed for health systems, large ambulatory care facilities, and healthcare marketing organizations. This release equips these organizations with data that more accurately attributes marketing-driven patient leads, prioritizes high-value appointments, and provides alerts f

    8/11/25 9:00:00 AM ET
    $MCHX
    Real Estate

    Marchex to Report Second Quarter 2025 Financial Results on Tuesday, August 12, 2025

    Marchex (NASDAQ:MCHX), which harnesses the power of AI and conversational intelligence to drive operational excellence and revenue acceleration, today announced that it will release financial results for the second quarter ended June 30, 2025, on August 12, 2025, at approximately 4:20 p.m. ET. At that time, Marchex will post the press release in the Press Center section of its corporate website (https://www.marchex.com/about-us/press/). Following the release, management will hold a conference call at 5:00 p.m. ET on August 12, 2025, to discuss the results and outlook for the company. A live webcast will be available on the Investors section of the Marchex website (http://investors.marchex

    8/1/25 9:00:00 AM ET
    $MCHX
    Real Estate

    $MCHX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Roth Capital reiterated coverage on Marchex with a new price target

    Roth Capital reiterated coverage of Marchex with a rating of Buy and set a new price target of $4.00 from $4.75 previously

    12/28/21 10:26:27 AM ET
    $MCHX
    Real Estate

    Roth Capital reiterated coverage on Marchex with a new price target

    Roth Capital reiterated coverage of Marchex with a rating of Buy and set a new price target of $4.75 from $3.50 previously

    2/24/21 4:18:40 PM ET
    $MCHX
    Real Estate

    $MCHX
    SEC Filings

    View All

    SEC Form 10-Q filed by Marchex Inc.

    10-Q - MARCHEX INC (0001224133) (Filer)

    8/13/25 4:16:49 PM ET
    $MCHX
    Real Estate

    Marchex Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - MARCHEX INC (0001224133) (Filer)

    8/12/25 4:20:09 PM ET
    $MCHX
    Real Estate

    SEC Form 10-Q filed by Marchex Inc.

    10-Q - MARCHEX INC (0001224133) (Filer)

    5/14/25 4:15:22 PM ET
    $MCHX
    Real Estate

    $MCHX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    $MCHX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Edenbrook Capital, Llc bought $52,827 worth of Class B common stock (30,962 units at $1.71) and bought $125,002 worth of Class B Common Stock (71,513 units at $1.75) (SEC Form 4)

    4 - MARCHEX INC (0001224133) (Issuer)

    3/27/25 5:42:35 PM ET
    $MCHX
    Real Estate

    Chief Executive Officer Miller Edwin A bought $9,982 worth of Class B Common Stock (5,787 units at $1.72), increasing direct ownership by 2% to 336,761 units (SEC Form 4)

    4 - MARCHEX INC (0001224133) (Issuer)

    11/19/24 4:15:03 PM ET
    $MCHX
    Real Estate

    Chief Executive Officer Miller Edwin A bought $182,548 worth of Class B Common Stock (105,571 units at $1.73), increasing direct ownership by 47% to 330,974 units (SEC Form 4)

    4 - MARCHEX INC (0001224133) (Issuer)

    11/15/24 4:15:04 PM ET
    $MCHX
    Real Estate

    Large owner Edenbrook Capital, Llc bought $52,827 worth of Class B common stock (30,962 units at $1.71) and bought $125,002 worth of Class B Common Stock (71,513 units at $1.75) (SEC Form 4)

    4 - MARCHEX INC (0001224133) (Issuer)

    3/27/25 5:42:35 PM ET
    $MCHX
    Real Estate

    SEC Form 4 filed by Chief Executive Officer Miller Edwin A

    4 - MARCHEX INC (0001224133) (Issuer)

    3/21/25 4:20:03 PM ET
    $MCHX
    Real Estate

    SEC Form 4 filed by Chief Revenue Officer Hartless Troy

    4 - MARCHEX INC (0001224133) (Issuer)

    3/21/25 4:20:04 PM ET
    $MCHX
    Real Estate

    $MCHX
    Leadership Updates

    Live Leadership Updates

    View All

    Marchex Adds Paul Gallagher as Vice President of Channel Sales to Drive Strategic Growth and Expand Its Channel Presence

    Seasoned executive brings extensive experience building high-performing partner ecosystems and scaling revenue across SaaS and data-driven businesses. Marchex (NASDAQ:MCHX), which harnesses the power of AI and conversational intelligence to drive revenue acceleration and operational excellence, today announced the appointment of Paul Gallagher as Vice President of Channel Sales. In this new role, Gallagher will be responsible for executing a high-impact channel strategy that accelerates Marchex's reach and revenue through strategic partnerships and alliances. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250717297160/en/Paul

    7/17/25 11:00:00 AM ET
    $MCHX
    Real Estate

    Marchex Partners with Microsoft for AI-Based Solution Offerings in Cloud AI

    Microsoft customers worldwide will soon gain access to Marchex's leading vertical market AI data analytics solutions to drive operational excellence and shape business strategies. Marchex (NASDAQ:MCHX), which harnesses the power of AI and conversational intelligence to drive operational excellence and revenue acceleration, today announced that it has signed an agreement to join the Microsoft Cloud AI Partner Program, including the ability to transact through Microsoft Azure Marketplace, which connects customers to Marchex solutions at scale. This collaboration enables Marchex to unlock sales growth as customers maximize their committed Microsoft cloud investments and expand into new sal

    12/11/24 9:00:00 AM ET
    $MCHX
    Real Estate

    Marchex Appoints Edwin Miller as New CEO

    Ryan Polley, Chief Operating Officer, Also Promoted to the Role of President Marchex, Inc. (NASDAQ:MCHX), the award-winning AI-powered conversation intelligence company that helps businesses turn strategic insights into the actions that drive their most valued sales outcomes, today announced that Edwin Miller has joined the company as its CEO. Russell Horowitz, Marchex's Chairman of the Board, will continue in this role and Michael Arends will serve as the company's Vice Chairman. A highly experienced entrepreneur and technology industry executive who has led and managed numerous dynamic organizations, Miller most recently was an operating executive with Gemspring Capital, a private equit

    2/6/23 9:00:00 AM ET
    $MCHX
    Real Estate

    $MCHX
    Financials

    Live finance-specific insights

    View All

    Marchex Announces Second Quarter 2025 Results

    Marchex, Inc. (NASDAQ:MCHX), which harnesses the power of AI and conversational intelligence to drive operational excellence and revenue acceleration, today announced its financial results for the second quarter ended June 30, 2025. Q2 2025 Financial Highlights GAAP revenue was $11.7 million for the second quarter of 2025, compared to $12.1 million for the second quarter of 2024. Net income was $0.1 million for the second quarter of 2025 or $0.00 per diluted share, compared to a net loss of $0.8 million or $(0.02) per diluted share for the second quarter of 2024. Adjusted earnings before interest, taxes, depreciation, and amortization ("EBITDA") was a gain of $0.6 million for the

    8/12/25 4:15:00 PM ET
    $MCHX
    Real Estate

    Marchex to Report Second Quarter 2025 Financial Results on Tuesday, August 12, 2025

    Marchex (NASDAQ:MCHX), which harnesses the power of AI and conversational intelligence to drive operational excellence and revenue acceleration, today announced that it will release financial results for the second quarter ended June 30, 2025, on August 12, 2025, at approximately 4:20 p.m. ET. At that time, Marchex will post the press release in the Press Center section of its corporate website (https://www.marchex.com/about-us/press/). Following the release, management will hold a conference call at 5:00 p.m. ET on August 12, 2025, to discuss the results and outlook for the company. A live webcast will be available on the Investors section of the Marchex website (http://investors.marchex

    8/1/25 9:00:00 AM ET
    $MCHX
    Real Estate

    Marchex to Report First Quarter 2025 Financial Results on Tuesday, May 13, 2025

    Marchex (NASDAQ:MCHX), which harnesses the power of AI and conversational intelligence to drive operational excellence and revenue acceleration, today announced that it will release financial results for the first quarter ended March 31, 2025, on May 13, 2025, at approximately 4:20 p.m. ET. At that time, Marchex will post the press release in the Press Center section of its corporate website (https://www.marchex.com/about-us/press/). Following the release, management will hold a conference call at 5:00 p.m. ET on May 13, 2025, to discuss the results and outlook for the company. A live webcast will be available on the Investors section of the Marchex website (http://investors.marchex.com/fi

    5/7/25 9:00:00 AM ET
    $MCHX
    Real Estate

    $MCHX
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    Insider Trading: Significant Buy at Marchex Inc. on Jun 5

    On June 5, 2024, Miller Edwin A made a significant insider purchase at Marchex Inc., acquiring $272,000 worth of Class B Common Stock, amounting to 200,000 units at a price of $1.36 per unit. This transaction represented a substantial increase in direct ownership by 1,107%, bringing Edwin A's total holdings to 218,066 units as reported in the SEC Form 4. Examining this purchase in the context of previous insider activities reveals interesting patterns worth noting. Horowitz Russell C was granted 15,000 units of Class B Common Stock on October 2, 2023, resulting in a 2% increase in direct ownership to 991,918 units. Similarly, Wisehart Manuel W was granted 15,000 units on the same date, incr

    6/10/24 1:01:02 AM ET
    $MCHX
    Real Estate

    $MCHX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Marchex Inc.

    SC 13G - MARCHEX INC (0001224133) (Subject)

    2/14/24 12:00:04 PM ET
    $MCHX
    Real Estate

    SEC Form SC 13G/A filed by Marchex Inc. (Amendment)

    SC 13G/A - MARCHEX INC (0001224133) (Subject)

    2/9/24 12:59:36 PM ET
    $MCHX
    Real Estate

    SEC Form SC 13D/A filed by Marchex Inc. (Amendment)

    SC 13D/A - MARCHEX INC (0001224133) (Subject)

    11/13/23 5:02:02 PM ET
    $MCHX
    Real Estate